The Priority Date of 23/08/12 is valid, as a Provisional Patent Application was filed in India on that date (in the name of Strides Arcolab Limited). The filing date refers to the non-provisional patent application which was filed 12 months later.
Therefore, with respect to timing, Strides/Agila’s filing of a provisional TPM/daptomycin patent application occurred two months before signing an exclusive global license agreement with Phosphagenics for use of TPM technology in a daptomycin injectable product, and some time after signing a Master Research Agreement with Phosphagenics in 2011.
POH Price at posting:
1.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)